The diagnostic performance of classical molecular tests used for detecting human papillomavirus

Journal of Virological Methods

Volumn 185, Issue 1, 2012, Pages 32-38

  Munoz, Marina ^a,b   Camargo, Milena ^a,b   Soto De Leon, Sara C ^a,b   Rojas Villarraga, Adriana ^b,d   Sanchez, Ricardo ^a,c   Jaimes, Camilo ^b   Perez Prados, Antonio ^e   Patarroyo, Manuel E ^a,c   Patarroyo, Manuel A ^a,b  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^d Center for Autoimmune Diseases Research (CREA)   (Colombia)

^e PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

Human papillomavirus; Hybrid capture assay 2; Polymerase chain reaction; Screening; Test performance

Indexed keywords

VIRUS DNA;

ABNORMAL LABORATORY RESULT; ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HYBRID CAPTURE ASSAY 2; INTERMETHOD COMPARISON; NONHUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; POST TEST PROBABILITY; PRIORITY JOURNAL; STATISTICAL PARAMETERS; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS DNA CELL DNA INTERACTION; WART VIRUS;

ADULT; CERVIX UTERI; COLPOSCOPY; CYTOLOGICAL TECHNIQUES; FEMALE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; SENSITIVITY AND SPECIFICITY; VIROLOGY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 84864324188     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.05.023     Document Type: Article

References (40)

1. Bosch F.X., de Sanjose S. Human papillomavirus in cervical cancer. Current Oncology Reports 2002, 4:175-183.
2. Bosch F.X., de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer - burden and assessment of causality. Journal of the National Cancer Institute 2003, 3-13.
3. Carestiato F.N., Silva K.C., Dimetz T., Oliveira L.H., Cavalcanti S.M. Prevalence of human papillomavirus infection in the genital tract determined by hybrid capture assay. Brazilian Journal of Infectious Diseases 2006, 10:331-336.
4. Castellsague X., Bosch F.X., Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Research 2002, 89:191-199.
5. Castle P.E., Lorincz A.T., Scott D.R., Sherman M.E., Glass A.G., Rush B.B., Wacholder S., Burk R.D., Manos M.M., Schussler J.E., Macomber P., Schiffman M. Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer. Journal of Clinical Microbiology 2003, 41:4022-4030.
6. Cox J.T., Lorincz A.T., Schiffman M.H., Sherman M.E., Cullen A., Kurman R.J. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology 1995, 172:946-954.
7. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. The Journal of General Virology 1995, 76(Pt 4):1057-1062.
8. de Sanjose S., Diaz M., Castellsague X., Clifford G., Bruni L., Munoz N., Bosch F.X. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infectious Diseases 2007, 7:453-459.
9. Franco E.L., Schlecht N.F., Saslow D. The epidemiology of cervical cancer. Cancer Journal (Sudbury, MA) 2003, 9:348-359.
10. Fujinaga Y., Shimada M., Okazawa K., Fukushima M., Kato I., Fujinaga K. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. The Journal of General Virology 1991, 72(Pt 5):1039-1044.
11. Giorgi Rossi P., Bisanzi S., Paganini I., Di Iasi A., Angeloni C., Scalisi A., Macis R., Pini M.T., Chini F., Carozzi F.M. Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study. BMC Infectious Diseases 2010, 10:214.
12. Girianelli V.R., Azevedo E.S.G., Thuler L.C. Factors associated with the risk of progression to precursor lesions or cervical cancer in women with negative cytologic findings. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 2009, 107:228-231.
13. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A., Schiffman M.H., Scott D.R., Apple R.J. Improved amplification of genital human papillomaviruses. Journal of Clinical Microbiology 2000, 38:357-361.
14. Iftner T., Villa L.L. Chapter 12: Human papillomavirus technologies. Journal of the National Cancer Institute 2003, 80-88.
15. Jastania R., Geddie W.R., Chapman W., Boerner S. Characteristics of apparently false-negative digene hybrid capture 2 high-risk HPV DNA testing. American Journal of Clinical Pathology 2006, 125:223-228.
16. Kinney W., Stoler M.H., Castle P.E. Special commentary: patient safety and the next generation of HPV DNA tests. American Journal of Clinical Pathology 2010, 134:193-199.
17. Kumar K., Iyer V.K., Bhatla N., Kriplani A., Verma K. Comparative evaluation of smear cytology & hybrid capture II for the diagnosis of cervical cancer. Indian Journal of Medical Research 2007, 126:39-44.
18. Lema C.H., Hurtado L.V., Segurondo D., Romero F., Dulon A., Asturizaga D., Panoso W., Garcia G., Fujiyoshi T., Yashiki S., Li H.C., Lou H., Cervantes J., Gomez L.H., Sonoda S. Human papillomavirus infection among Bolivian Amazonian women. Asian Pacific Journal of Cancer Prevention 2001, 2:135-141.
19. Lorincz A.T. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. The Journal of Obstetrics and Gynaecology Research 1996, 22:629-636.
20. Molano M., Posso H., Weiderpass E., van den Brule A.J., Ronderos M., Franceschi S., Meijer C.J., Arslan A., Munoz N. Prevalence and determinants of HPV infection among Colombian women with normal cytology. British Journal of Cancer 2002, 87:324-333.
21. Molijn A., Kleter B., Quint W., van Doorn L.J. Molecular diagnosis of human papillomavirus (HPV) infections. Journal of Clinical Virology 2005, 32(Suppl. 1):S43-S51.
22. Moscicki A.B., Schiffman M., Kjaer S., Villa L.L. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 2006, 24(Suppl. 3). S3/42-51.
23. Munoz N., Castellsague X., de Gonzalez A.B., Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006, 24(Suppl. 3). S3/1-10.
24. Nanda K., McCrory D.C., Myers E.R., Bastian L.A., Hasselblad V., Hickey J.D., Matchar D.B. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Annals of Internal Medicine 2000, 132:810-819.
25. Poljak M., Brencic A., Seme K., Vince A., Marin I.J. Comparative evaluation of first- and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer. Journal of Clinical Microbiology 1999, 37:796-797.
26. Posso, H.J., Wiesner, C., Piñeros, M., Hernando, R., González, M., Tovar, S.L., 2005. Acciones en el plan obligatorio de salud. Manual de normas técnico - administrativas para el programa de detección y control del cáncer de cuello uterino en el sistema general de seguridad en salud, Bogotá, Colombia, p. 190.
27. Qu W., Jiang G., Cruz Y., Chang C.J., Ho G.Y., Klein R.S., Burk R.D. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. Journal of Clinical Microbiology 1997, 35:1304-1310.
28. Rauber D., Mehlhorn G., Fasching P.A., Beckmann M.W., Ackermann S. Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2008, 140:258-262.
29. Remmerbach T.W., Brinckmann U.G., Hemprich A., Chekol M., Kuhndel K., Liebert U.G. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. Journal of Clinical Virology 2004, 30:302-308.
30. Saiki R.K., Scharf S., Faloona F., Mullis K.B., Horn G.T., Erlich H.A., Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (New York, NY) 1985, 230:1350-1354.
31. Schlecht N.F., Kulaga S., Robitaille J., Ferreira S., Santos M., Miyamura R.A., Duarte-Franco E., Rohan T.E., Ferenczy A., Villa L.L., Franco E.L. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001, 286:3106-3114.
32. Schwartz, A., 2002-2007. Diagnostic test calculator (version 2006032401).
33. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., Raab S., Sherman M., Wilbur D., Wright T., Young N. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287:2114-2119.
34. Soto-De Leon S.C., Camargo M., Sanchez R., Leon S., Urquiza M., Acosta J., Monsalve D., Rodriguez L.E., Patarroyo M.E., Patarroyo M.A. Prevalence of infection with high-risk human papillomavirus in women in Colombia. Clinical Microbiology and Infection 2009, 15:93-102.
35. Tabora N., Bakkers J.M., Quint W.G., Massuger L.F., Matute J.A., Melchers W.J., Ferrera A. Human papillomavirus infection in Honduran women with normal cytology. Cancer Causes and Control 2009, 20:1663-1670.
36. Uribe C., Díaz L., Ortiz R., Meza E. Pap smear prevalence and that of pre-malignant and malignant cervical lesions amongst women living in the carmen initiative demonstration area, Bucaramanga, Colombia. Revista Colombiana de Obstetricia y Ginecología 2006, 57:10-18.
37. Vernick J.P., Steigman C.K. The HPV DNA virus hybrid capture assay: what is it and where do we go from here?. MLO: Medical Laboratory Observer 2003, 35:8-10. 13; quiz 14-15.
38. WHO/ICO, Summary Report 2010. Information Centre on HPV and Cervical Cancer (HPV Information Center). Human Papillomavirus and Related Cancers in Colombia. Available at: http://www.who.int/hpvcentre.
39. Wu S., Meng L., Wang S., Ma D. A comparison of four screening methods for cervical neoplasia. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 2005, 91:189-193.
40. Zhou X.-H., Obuchowski N.A., McClish D.K. Methods for Correcting Imperfect Standard Bias 2008, John Wiley & Sons Inc.